Related Experiment Video
Updated: Jan 9, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Left Ventricular Mass Index and Relative Wall Thickness Predict Atrial High-Rate Episodes in Patients With Pacemaker
Qin Zhang1, Limin Xiang2, Gege Zhao3
1Department of Cardiology, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, China.
Atrial high-rate episodes (AHREs) after cardiac device implantation are predicted by echocardiographic indices. Left ventricular mass index (LVMI) and relative wall thickness (RWT) are independent predictors of AHREs, guiding early intervention.
Area of Science:
- Cardiology
- Medical Devices
- Echocardiography
Background:
- Atrial high-rate episodes (AHREs) post-cardiac implantable electronic device (CIED) implantation are linked to stroke risk.
- Echocardiographic indices like left ventricular mass index (LVMI) and relative wall thickness (RWT) may predict AHREs.
Purpose of the Study:
- To investigate the predictive value of LVMI and RWT for AHREs following CIED implantation.
- To identify echocardiographic predictors of AHREs in patients receiving pacemakers.
Main Methods:
- Retrospective single-center study of 122 patients undergoing dual-chamber pacemaker implantation.
- Analysis of clinical data, serological markers, and echocardiographic indices.
- Cox regression and ROC curve analysis to determine predictors and predictive value of LVMI and RWT for AHREs.
Main Results:
- Lower RWT and higher LVMI were independently associated with an increased risk of AHREs.
- ROC analysis indicated predictive values for LVMI (AUC=0.722) and RWT (AUC=0.716).
- Patients with LVMI ≥ 114.930 or RWT < 0.392 showed a higher incidence of AHREs.
Conclusions:
- LVMI and RWT are independent predictors of AHREs after pacemaker implantation.
- Specific thresholds for LVMI (≥ 114.930) and RWT (< 0.392) identify high-risk patients.
- These findings support early clinical intervention for patients at high risk of AHREs.
Related Concept Videos
Mitral Stenosis II: Clinical features and Diagnostic Tests
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Valve Prolapse II: Assessment and Management
Mitral Regurgitation I: Introduction
Mitral Stenosis I: Introduction

